K. Kitayama

发表

Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.

E. D. de Wit, D. Nakai, T. Inaba, 2006, European journal of pharmacology.

A novel compound, R-138329, increases plasma HDL cholesterol via inhibition of scavenger receptor BI-mediated selective lipid uptake.

T. Nishizawa, T. Oda, M. Yamada, 2007, Atherosclerosis.

Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits

H. Koike, T. Inaba, M. Mizuno, 2005, Journal of cardiovascular pharmacology.

Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.

T. Koga, T. Inaba, K. Kitayama, 2006, European journal of pharmacology.

Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.

T. Koga, T. Inaba, K. Kitayama, 2006, European journal of pharmacology.

Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.

T. Koga, T. Inaba, N. Terasaka, 2006, European journal of pharmacology.

ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice.

T. Inaba, N. Terasaka, Tadashi Koieyama, 2007, Atherosclerosis.

Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice

T. Nishizawa, T. Oda, K. Wakabayashi, 2006, The Journal of pharmacy and pharmacology.

A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives.

T. Hasegawa, T. Inaba, T. Kohama, 2004, Bioorganic & medicinal chemistry letters.